Design and Synthesis of Novel Biginelli Adducts: Anticancer Activity and In Silico Study.

Authors

Aida Iraji, Sara Moghadam Farid, Mohammadreza Eftekharian, Paniz Naseri, Mohammad Mahdavi, Mina Saeedi, Tahmineh Akbarzadeh

Published in

Chemistry & biodiversity. Volume 23. Issue 10. Pages e71810.

Abstract

In this study, we report the synthesis of 14 Biginelli adducts and the evaluation of their anticancer activity against three human cancer cell lines: MCF-7 (breast), SW480 (colon), and Hep-G2 (liver), as well as the noncancerous Hek-293 cell line. Among the synthesized derivatives, compound 8n emerged as the most potent, inducing significant cytotoxicity and apoptosis in MCF-7 cells. Structure-activity relationship (SAR) analysis showed that specific modifications, such as methyl and nitro substitutions, enhanced anticancer activity, whereas bulky substituents reduced potency. Further investigations confirmed that compound 8n induces cell cycle arrest at the S and G2/M phases, highlighting its antiproliferative mechanism. Molecular docking and molecular dynamics simulations suggest that compound 8n could bind to Eg5, a potential regulator of cell division. However, this study did not include direct biochemical testing of the protein target (Eg5).

PMID:
42860863
Bibliographic data and abstract were imported from PubMed on 12 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.